Lifesource Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 29 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 Cr
as on 10-12-2024
- Satisfied Charges ₹ 2.40 Cr
as on 10-12-2024
- Revenue 0.85%
(FY 2021)
- Profit 2.67%
(FY 2021)
- Ebitda 98.78%
(FY 2021)
- Net Worth 15.17%
(FY 2021)
- Total Assets 14.63%
(FY 2021)
About Lifesource Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.00 Cr. The company has closed loans amounting to ₹2.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Radheshyam Kedia and Sita Ruia serve as directors at the Company.
- CIN/LLPIN
U24300MH1995PTC093516
- Company No.
093516
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Oct 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Lifesource Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Radheshyam Kedia  | Director | 11-Oct-1995 | Current |
| Sita Ruia | Director | 17-Dec-1998 | Current |
Financial Performance of Lifesource Pharmaceuticals.
Lifesource Pharmaceuticals Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 0.85% increase. The company also saw a slight improvement in profitability, with a 2.67% increase in profit. The company's net worth Soared by an impressive increase of 15.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lifesource Pharmaceuticals?
In 2020, Lifesource Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 May 2017 | ₹3.00 Cr | Open |
Indusind Bank Ltd. Creation Date: 27 Feb 2004 | ₹2.40 Cr | Satisfied |
How Many Employees Work at Lifesource Pharmaceuticals?
Unlock and access historical data on people associated with Lifesource Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lifesource Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lifesource Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
